Trilogy Capital
AMGN icon

Trilogy Capital’s Amgen AMGN Stock Holding History

Trilogy Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$594K Buy
1,409
+576
+69% +$230K 0.02% 260
2026
Q2 		$302K Sell
833
-9,302
-92% -$3.18M 0.01% 331
2026
Q1 		$3.57M Sell
10,135
-255
-2% -$90.9K 0.16% 103
2025
Q4 		$3.4M Buy
10,390
+96
+0.9% +$30.5K 0.15% 114
2025
Q3 		$2.9M Sell
10,294
-423
-4% -$123K 0.13% 114
2025
Q2 		$2.99M Sell
10,717
-285
-3% -$80.7K 0.15% 104
2025
Q1 		$3.43M Buy
11,002
+74
+0.7% +$21.9K 0.18% 79
2024
Q4 		$2.85M Buy
10,928
+886
+9% +$263K 0.15% 110
2024
Q3 		$3.24M Sell
10,042
-207
-2% -$67.7K 0.16% 100
2024
Q2 		$3.2M Buy
10,249
+329
+3% +$96.7K 0.17% 92
2024
Q1 		$2.82M Buy
9,920
+360
+4% +$105K 0.16% 110
2023
Q4 		$2.75M Sell
9,560
-665
-7% -$181K 0.17% 99
2023
Q3 		$2.75M Buy
+10,225
New +$2.55M 0.19% 76
2022
Q1 		– Sell
-1,365
Closed -$307K – 168
2021
Q4 		$307K Sell
1,365
-110
-7% -$23.2K 0.02% 142
2021
Q3 		$314K Buy
1,475
+1
+0.1% +$230 0.02% 131
2021
Q2 		$360K Buy
+1,474
New +$363K 0.03% 130
2020
Q1 		– Sell
-1,305
Closed -$311K – 103
2019
Q4 		$311K Hold
1,305
– – 0.03% 102
2019
Q3 		$255K Buy
1,305
+1
+0.1% +$192 0.03% 104
2019
Q2 		$238K Sell
1,304
-140
-10% -$25.1K 0.03% 106
2019
Q1 		$274K Sell
1,444
-101
-7% -$19.3K 0.03% 103
2018
Q4 		$301K Buy
1,545
+201
+15% +$39.2K 0.04% 107
2018
Q3 		$279K Buy
1,344
+47
+4% +$9.26K 0.03% 117
2018
Q2 		$239K Buy
1,297
+151
+13% +$26.7K 0.03% 112
2018
Q1 		$195K Buy
+1,146
New +$210K 0.03% 115

Other funds holding AMGN

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Smead Capital Management
Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Trilogy Capital's AMGN Position: Q3 2026 in Review

Trilogy Capital increased its Amgen (AMGN) stake by 69% in Q3 2026, buying an estimated $230K and bringing the position to 1,409 shares worth $594K. The position accounts for 0.02% of the portfolio, ranked #260.

Trilogy Capital first reported a position in AMGN in Q1 2018 and has held it in 24 quarters since. The position peaked at $3.57M in Q1 2026. 1,494 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Trilogy Capital held 1,409 shares of Amgen worth $594K as of Q3 2026.
  • Trilogy Capital bought 576 Amgen shares in Q3 2026, an estimated $230K.
  • Amgen made up 0.02% of Trilogy Capital's portfolio in Q3 2026, its #260 holding.
  • Trilogy Capital first reported a position in Amgen in Q1 2018 and has held it in 24 quarters since.
  • Trilogy Capital's Amgen position peaked at $3.57M in Q1 2026.
  • 1,494 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.